Cervical Screening Negligence Claims in Ireland: Your Rights After the CervicalCheck Tribunal Closed (2026)

You can still bring a cervical screening negligence claim in Ireland, but the route has changed. The CervicalCheck Tribunal was dissolved on 30 January 2026 by Ministerial Order (S.I. No. 19/2026, made 27 January 2026), and all new claims now proceed in the High Court. The legal test is the "reasonable competence" standard confirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6 (judgment of 19 March 2020), and the time limit is two years from your date of knowledge under the Statute of Limitations (Amendment) Act 1991, s.2.

Bottom line for women considering a cervical screening negligence claim

• The Tribunal is closed. Since 30 January 2026, new cervical screening claims issue in the High Court Clinical Negligence List, not the Tribunal.
• The legal test is the Dunne and Morrissey "reasonable competence" standard. A screener or laboratory is liable where no other screener of equal skill, exercising ordinary care, would have passed the slide as clear.
• The clock is two years from when you knew enough to act, not from the smear date, and waiting for an expert report does not pause it.
• Compensation has three layers: general damages up to €550,000 for the most severe cases, special damages for lost earnings and care, and where relevant a tax-exempt €20,000 ex-gratia payment for non-disclosure.

Key facts at a glance

The numbers and dates that define these claims in Ireland as of 2026.

What	The number	Primary source
Tribunal dissolution date	30 January 2026	S.I. No. 19/2026
Time limit from date of knowledge	2 years	Statute of Limitations (Amendment) Act 1991, s.2
General damages cap, most severe cases	€550,000	Personal Injuries Guidelines 2021
Solatium for mental distress, shared among all dependants	€35,000 total	s.49 Civil Liability Act 1961, as amended by S.I. No. 6 of 2014
Non-disclosure ex-gratia scheme payment	€20,000 fixed	Department of Health scheme terms
Clinical claims resolved by mediation, 2024	43%	State Claims Agency Annual Report 2024
Clinical claims reaching full court judgment, 2024	Fewer than 2%	State Claims Agency Annual Report 2024
Tribunal outcome, 2020 to 2026	26 claims, zero awards	Department of Health figures reported by Irish Examiner, June 2025

Tribunal era vs High Court era: what changed on 30 January 2026

For six years, Irish women with cervical screening claims had two procedural routes. Since S.I. No. 19/2026 took effect on 30 January 2026, only one route remains. The table below sets out the practical difference for a woman deciding how to proceed.

Comparison of the Tribunal route (2020 to 2026) with the High Court route (from 28 April 2025 and exclusively from 30 January 2026).

Feature	CervicalCheck Tribunal (2020 to 30 Jan 2026)	High Court Clinical Negligence List (from 28 April 2025)
Availability for new claims	Closed to new claims	Open, all stages of the proceedings
Governing instrument	CervicalCheck Tribunal Act 2019	Practice Directions HC131 and HC132
Legal test for negligence	Dunne and Morrissey "reasonable competence" standard	Dunne and Morrissey "reasonable competence" standard (unchanged)
Hearings in public	No, private by default	Yes, subject to reporting restrictions for sensitive evidence
Mediation	Voluntary within Tribunal procedure	Undertaking to offer mediation is a condition of applying for a trial date under HC131
Typical resolution rate	Some settlements, no awards (zero full hearings to judgment)	43% of clinical claims resolved at mediation, fewer than 2% reach full judgment (SCA 2024 figures)
Judicial oversight	Tribunal chair, limited case-management power	Dedicated Judge in Charge of the Clinical Negligence List with case-management directions
Time limit for filing	Two-year date-of-knowledge rule under Statute of Limitations (Amendment) Act 1991, s.2	Two-year date-of-knowledge rule (same statutory basis)

Practically, the change simplifies the choice for women considering a claim. The question is no longer "Tribunal or court?". It is whether you have evidence of a screening failure that caused harm, and whether you can meet the two-year clock that runs from your date of knowledge.

Contents

Route now: High Court only. Tribunal dissolved 30 Jan 2026. S.I. 19/2026¹

Legal test: "Reasonable competence," not absolute confidence. Morrissey v HSE [2020] IESC 6⁹

Time limit: Two years from date of knowledge. 1991 Act s.2¹²

IRB bypass: Clinical negligence goes directly to court. PIAB Act 2003 s.3(d)²⁰

Self-audit: do you potentially have a cervical screening negligence claim?

This quick check is general guidance only, not legal advice. Answering "yes" to several of the questions below suggests a solicitor's assessment would be worthwhile. Every case turns on its own facts.

• Have you been diagnosed with cervical cancer, or told of serious pre-cancerous changes, within the last 10 years?
• Did you attend routine CervicalCheck smear tests before the diagnosis?
• Have any of those smears now been reviewed and found to be discordant, or are you still awaiting a personal cervical screening review finding?
• Were you told about a retrospective audit finding less than two years ago, or have you not yet been formally told?
• Did a GP or colposcopy clinic fail to act on a positive HPV result or abnormal cytology within the expected timeframe?
• Have you received a fixed €20,000 payment from the non-disclosure ex-gratia scheme but no separate negligence settlement?

A "yes" to any question above does not prove a claim. It does indicate that an assessment with a solicitor experienced in clinical negligence is worthwhile before the two-year limitation window closes.

Quick answers for common cervical screening negligence questions

Is the Tribunal still open? No. Dissolved 30 January 2026 under S.I. No. 19/2026.

What's the time limit? Two years from your date of knowledge under the 1991 Act s.2.

Do I go to the IRB first? No. Medical negligence bypasses the IRB under PIAB Act 2003 s.3(d).

What's the legal test? The Morrissey "reasonable competence" standard, not Bolam.

Where does the claim go? High Court Clinical Negligence List under HC132.

Is mediation required? Effectively yes, under HC131 before any trial date.

Are settlements taxed? No. Income Tax, CGT, DIRT, and Exit Tax all exempt.

Can family claim after death? Yes, under Part IV of the Civil Liability Act 1961.

Fast facts about cervical screening negligence in Ireland

Jurisdiction: All new claims proceed in the High Court of Ireland. The CervicalCheck Tribunal closed 30 January 2026.

The controlling authority is Morrissey v HSE [2020] IESC 6 from the Supreme Court, applying the principles set out in Dunne v National Maternity Hospital [1989] IR 91.

Limitation: Two years from date of knowledge, per Statute of Limitations (Amendment) Act 1991, s.2.

Mediation rate: Approximately 43% of clinical negligence claims with damages resolve at mediation, per SCA 2024 data.

Ex-gratia option: €20,000 non-disclosure payment remains available alongside a negligence claim, not instead of it.

Can I still make a cervical screening negligence claim in Ireland?

Yes. Since the CervicalCheck Tribunal (Dissolution) Order 2026¹ took effect on 30 January 2026, every new cervical screening negligence claim in Ireland issues in the High Court Clinical Negligence List. The legal test is unchanged, and the two-year limitation clock still runs from your date of knowledge.

A cervical screening negligence claim arises where a smear test was misread, a positive HPV result was not acted on, or a follow-up colposcopy referral was missed, and that failure caused a patient avoidable harm. The Tribunal's legal life ended on 30 January 2026, and all residual matters fall to the Department of Health.

The State Claims Agency (SCA) continues to manage the defence of these cases on behalf of the HSE. The SCA Annual Report 2024 confirms that the Agency paid €210.5 million in clinical care damages during that year and managed a portfolio with outstanding liabilities of €5.35 billion. That context matters: cervical screening claims sit inside the largest clinical negligence caseload on the State's books.

What happened to the CervicalCheck Tribunal?

The CervicalCheck Tribunal was formally dissolved on 30 January 2026 after concluding all statutory business. It received 26 claims over six years, held zero full hearings to judgment, and recorded administrative costs of €3,445,449. Filing with the Tribunal is no longer possible in 2026.

Set up under the CervicalCheck Tribunal Act 2019 to offer a non-adversarial route for women affected by the screening scandal, the Tribunal has since been wound down. Oireachtas records and the Irish Examiner reporting of 20 June 2025 set the final administrative costs at €3,445,449 excluding member remuneration.

The dissolution matters for anyone researching cervical screening claims today because many older online guides still point claimants towards a Tribunal that no longer exists. Filing a Form 1 with the Tribunal is no longer possible. The only live route is the High Court.

Key dates in the shift from Tribunal to High Court

The 2025-2026 procedural shift in Irish cervical screening litigation

Date	Event	Consequence for claimants
28 April 2025	Practice Directions HC131 and HC132 take effect	Clinical Negligence List established, mediation becomes effectively mandatory pre-trial
28 February 2024	CervicalCheck Tribunal submits final annual report to Minister for Health	Tribunal enters wind-down phase
30 January 2026	CervicalCheck Tribunal dissolved under S.I. No. 19/2026	All new claims must issue in the High Court
Q1 2026 onward	Post-dissolution High Court listings of cervical screening claims	First cohort of fully post-dissolution cases case-managed under HC132

The High Court route: HC131, HC132, and the mediation requirement

All new cervical screening claims now proceed through the dedicated Clinical Negligence List established under Practice Direction HC132. Effective from 28 April 2025, the list brings every stage of a clinical negligence action, including mediation supervision and final hearings, under focused judicial case management⁷.

What HC131 means for trial dates

Practice Direction HC131 governs how a party applies for a trial date. A party must give 28 days' notice of the application to all affected parties, supported by a Certificate of Compliance signed by the solicitor confirming that the case is fully pleaded, expert evidence has been exchanged or offered, and special damages are particularised. The HC131 direction (2025) then requires the applicant to undertake to offer mediation within three weeks of the trial date being fixed and to engage within six weeks of the offer being accepted.

That mediation step isn't a ceremony. SCA data for 2024² records that 43% of clinical claims involving damages resolved at mediation, while fewer than 2% reached full judgment. A competent cervical screening claim is therefore prepared with both a trial-ready evidence bundle and a credible mediation strategy from the outset.

The Morrissey standard: how a screening claim is actually proved

The legal test for cervical screening negligence in Ireland is the "reasonable competence" standard confirmed by the Supreme Court in Morrissey v HSE [2020] IESC 6⁹. A screener or laboratory is liable where no other screener of equal skill, exercising ordinary care, would have passed the slide as clear.

The Supreme Court judgment of 19 March 2020 dismissed the HSE and laboratories' appeal against the High Court finding, and clarified that "absolute confidence" is a standard of approach which stemmed from the profession itself, rather than a separate higher legal test imposed by the court. The judgment re-affirmed the Dunne v National Maternity Hospital [1989] IR 91 principles as the controlling Irish framework.

Unlike in England and Wales, which apply the Bolam/Bolitho test asking whether a responsible body of medical opinion would support the practitioner's conduct, Ireland's Dunne test asks whether a reasonably competent practitioner of equal specialist status would have made the same error while exercising ordinary care. That difference matters: Irish courts place less weight on professional custom and more weight on what a competent peer would actually have detected on the slide.

The non-delegable duty of the HSE

Morrissey also fixed the HSE with a non-delegable duty of care to women screened through CervicalCheck. The HSE can't escape primary liability by pointing to the contracted laboratory. In the Morrissey award of €2.16 million, Quest Diagnostics and Medlab Pathology were each found negligent, and the HSE remained directly answerable to the patient for the screening programme it provided. The non-delegable duty principle draws on earlier authority including Byrne v Ryan [2007] IEHC 207 and applies to every claim arising from CervicalCheck, BreastCheck, or BowelScreen.

Causation and the Crumlish caution

Proving breach is only half of a cervical screening claim. The claimant must also prove, on the balance of probabilities, that earlier detection would have produced a better outcome. The Court of Appeal in Crumlish v HSE cautioned against relying on generic "tumour doubling time" academic literature to prove that a cancer would have been detectable at an earlier smear. Expert gynaecological oncology evidence grounded in the claimant's specific clinical picture is now essential.

Time limits and the "date of knowledge" rule

The strict time limit for this kind of claim in Ireland is two years, but the clock starts on your "date of knowledge," not the date of the misread smear¹². Unlike England and Wales, where the period is three years under the Limitation Act 1980, Ireland applies two.

Under Section 2 of the Statute of Limitations (Amendment) Act 1991 , knowledge means the date you first knew, or reasonably ought to have known, four things at once: that you had suffered a significant injury, that the injury was attributable to substandard care, the identity of those responsible, and that the injury was significant enough to justify proceedings. That shorter window makes the "date of knowledge" analysis more urgent here than in any UK guide a reader might find through a general Google search.

The Monaghan trap

A serious pitfall catches many claimants. The High Court held in Monaghan v Molony [2024] IEHC 287 that waiting for a medical expert report doesn't stop the clock. If you already have the foundational facts (for example, you received a letter confirming an earlier smear was misread), the two-year period begins running from that moment, even if you intend to seek an expert opinion later. Protective proceedings may be needed while evidence is gathered.

Exceptions and extensions

Two main exceptions apply to the two-year rule. First, if the person harmed is a minor, time doesn't run until their eighteenth birthday. Second, if the person lacks the mental capacity to manage their own affairs, the clock is suspended under the Statute of Limitations until capacity returns. According to the Citizens Information guidance on civil time limits (2025), these exceptions are narrowly construed, and claimants shouldn't rely on them without legal advice.

Post-2020 HPV primary screening claims: the new failure modes

Ireland moved to HPV primary screening in March 2020, which changed both the science of the test and the architecture of a negligence claim. Samples are first analysed for high-risk HPV strains, and only HPV-positive samples progress to cytological review. The shift has reduced false negatives compared with the pre-2020 cytology-first model¹⁴.

According to the HSE's CervicalCheck programme materials (2025), this shift has reduced false-negative rates compared with the cytology-first model that triggered the 2018 scandal. Claims arising from the HPV era are increasingly rooted in systemic, procedural, or administrative failure rather than pure slide-reading error. The main failure modes we now see in practice include specimen collection failures, HPV triage and algorithmic errors, administrative recall negligence, and what commentators call "vaccine assumption bias," where a clinician dismisses red-flag symptoms because a woman received the Gardasil 9 vaccine. The vaccine doesn't cover every oncogenic HPV strain, and dismissing symptomatic presentation on that basis can breach the diagnostic duty of care.

Cervical screening negligence failure modes in Ireland, pre- and post-March 2020

Failure mode	Typical era	What the evidence looks like
Cytology slide misread as normal	Pre-March 2020 (primary), still possible post-2020 on reflex cytology	Independent cytologist re-read of original slide
HPV test false negative	Post-March 2020	Lab audit of reagent batches, protocol breaches, accreditation findings
Failure to refer for colposcopy	Both eras	GP notes, referral records, time-to-colposcopy data
Administrative recall failure	Both eras	Invitation letters, CervicalCheck register data
Audit non-disclosure	2008 to 2018 primarily	Retrospective audit result letters, open-disclosure failures

Personal cervical screening reviews: how to request yours

A personal cervical screening review is an independent, patient-requested look at your screening history after a cervical cancer diagnosis. The HSE's National Screening Service launched this process in April 2023, and it applies to any woman diagnosed with cervical cancer who had a CervicalCheck test in the ten years before diagnosis. According to the NSS announcement of 4 April 2023³, around 170 of the 290 women diagnosed annually are eligible to request a review.

To request a review you contact Client Services at the National Screening Service. The full postal address is King's Inns House, 200 Parnell Street, Dublin 1, D01 A3Y8, or you can email clientservices@screeningservice.ie. The HSE's own guidance at hse.ie/cervical-screening⁴ also lets you request the original slides for independent re-reading, which is often the most decisive step in a subsequent negligence claim.

Retrospective audit status by CervicalCheck cohort year

The CervicalCheck retrospective audit exercise uncovered distinct groups of affected women across different years. Reading this table helps you locate where your own screening history sits. From handling women's health misdiagnosis claims, the most common client question in a first meeting is "which cohort am I in?", because it drives both limitation analysis and the likely route to evidence.

CervicalCheck audit cohorts and review status in Ireland (education only, figures drawn from HSE, SCA, and Oireachtas records)

Cohort	Approximate numbers	Review source	Typical claim posture
Original "221+" cohort (pre-May 2018 diagnoses)	221 women initially identified	Internal CervicalCheck audit (2014-2017) plus Scally review	Most High Court claims concluded or mediated. Some estate claims remain
RCOG expert panel cohort (2008-2018 diagnoses)	1,038 slides reviewed, 159 additional discordant readings identified	Royal College of Obstetricians and Gynaecologists external review (published 2020)	Significant number of claims issued 2020-2024 based on RCOG findings
Personal review cohort (April 2023 onward)	Approximately 170 of 290 annual diagnoses eligible	Patient-requested personal cervical screening review	Date of knowledge often crystallises on receipt of review letter. Limitation analysis critical
HPV-era interval cancers (post-March 2020)	Estimated 20-30 interval cancers annually per HSE data11	Personal cervical screening review, investigations by NSS	Newer legal ground, claims centre on HPV triage or recall failure

Cohort figures are drawn from publicly reported HSE data and SCA annual reports. Your individual entitlement depends on your clinical history and the specific findings on your personal review.

Who can be named as defendant in a cervical screening claim

A cervical screening claim in Ireland is typically pleaded against the HSE together with the specific laboratory that processed the sample. Under the Morrissey non-delegable duty, the HSE remains a primary defendant even where the actual misread occurred in a contracted laboratory. Common laboratory defendants in historical CervicalCheck claims have included Quest Diagnostics Incorporated (New Jersey), Medlab Pathology Limited (Dublin), Clinical Pathology Laboratories Incorporated (Austin, Texas), and Eurofins Biomnis Ireland Limited (Sandyford).

Breaking News coverage of September 2022 noted that 368 CervicalCheck legal claims had been notified to the SCA, and the ratio of High Court claims to Tribunal claims was roughly 12:1 even before the Tribunal's dissolution. That figure reflects a plain reality: where the negligence is serious, the High Court has always been the chosen venue.

Private laboratories are not immune

Private laboratories can be sued directly. Data from the SCA's 2023 reporting period indicates that Medlab Pathology Limited alone paid approximately €26.86 million in CervicalCheck-related settlements during that single year, funded through its insurers. Private laboratory liability sits alongside HSE liability rather than replacing it.

Laboratories historically engaged under the Irish CervicalCheck programme, and their liability posture

Laboratory	Jurisdiction	Role in CervicalCheck	Service and liability note
Quest Diagnostics Incorporated	New Jersey, USA	Primary cytology processing (2008-2018)	Served out of jurisdiction, found negligent in Morrissey
Clinical Pathology Laboratories Incorporated	Austin, Texas, USA	Cytology processing (historical)	Served out of jurisdiction, named in multiple 221+ cohort claims
Medlab Pathology Limited	Dublin, Ireland	Cytology processing, named defendant in Morrissey	Approximately €26.86m paid in CervicalCheck settlements in 2023 alone (insurer-funded)
Eurofins Biomnis Ireland Limited	Sandyford, Dublin	Cytology processing (historical and current)	Irish-incorporated, served within jurisdiction
Health Service Executive	Ireland	Programme operator with non-delegable duty	Always a co-defendant under Morrissey, State Claims Agency defends

Laboratory involvement has shifted over time. The HSE transitioned to HPV primary testing in March 2020, and laboratory contracts have been re-tendered. Confirm the specific laboratory processing your smear at the date of the test.

Evidence that proves a cervical screening negligence claim

Strong cervical screening claims are built on a specific evidence bundle. From handling women's health misdiagnosis claims in Irish courts, the same five evidence layers tend to recur in every pleading that survives defendant scrutiny. We refer to this combination as the Five-Layer Evidence Bundle, and it maps directly to what HC131's Certificate of Compliance requires before a trial date is granted.

The single most decisive layer of the Five-Layer Evidence Bundle is almost always an independent cytologist's or gynaecological oncology expert's re-reading of the original smear slide against the Morrissey "reasonable competence" standard. Without that expert re-reading, a claim can't pass the Dunne breach-of-duty threshold, no matter how strong the other four layers look on paper.

Each of the five layers in the Five-Layer Evidence Bundle serves a distinct purpose. GP and hospital records establish the clinical timeline. CervicalCheck screening history identifies the exact smear dates and laboratory results. Original slides, independently re-read, determine whether a breach of duty occurred under Morrissey. The personal review finding (where available) crystallises the date of knowledge. The oncology report on causation bridges the breach to the claimant's clinical outcome. The next step is to understand how each layer is actually obtained in practice.

The slide request process in practical terms

To obtain your records and slides, write to Client Services at King's Inns House, 200 Parnell Street, Dublin 1, D01 A3Y8. According to the HSE records request page (2025)⁴, the NSS aims to respond within 30 working days. Include your full name, date of birth, address, contact number, a scanned copy of your photo ID, and a clear statement of whether you want records, slides for independent review, or both.

Key cervical screening and legal terms explained

Cervical screening negligence cases sit at the junction of cytopathology, gynaecological oncology, and Irish tort law. The glossary below defines the terms most often misunderstood by claimants coming to this material for the first time. In our experience, a clear grasp of the medical vocabulary makes every subsequent conversation with a solicitor or expert faster and less stressful.

Cervical screening and legal terms referenced in Irish negligence claims

Term	What it means
Cytology	The laboratory examination of cells. In cervical screening, cells collected from the cervix are examined microscopically for abnormalities.
Dyskaryosis	Abnormal nuclear changes in cervical cells identified on cytology. Graded as mild, moderate, or severe. A missed dyskaryosis on a cytology slide is the core allegation in classic Morrissey-type claims.
HR-HPV / high-risk HPV	Human papillomavirus strains (notably HPV 16 and 18) that cause the majority of cervical cancers. Ireland moved to HR-HPV primary testing in March 2020.
CIN1 / CIN2 / CIN3	Cervical Intraepithelial Neoplasia grades 1 to 3, describing the severity of pre-cancerous changes detected on colposcopy biopsy. CIN3 is the most severe stage before invasive cancer.
Colposcopy	A diagnostic procedure using a magnifying instrument to examine the cervix in detail and take targeted biopsies. Triggered by abnormal cytology or positive HR-HPV results.
LLETZ	Large Loop Excision of the Transformation Zone. An outpatient procedure to remove abnormal cervical tissue. A successful LLETZ after timely detection often prevents invasive cancer.
Interval cancer	A cervical cancer diagnosed between routine screenings. Not automatically evidence of negligence. Described by the HSE as an inherent feature of every screening programme.
Discordant reading	An earlier smear classification that differs from the finding on retrospective expert review. A discordant reading does not automatically equal negligence under Morrissey.
Date of knowledge	The point at which the two-year limitation clock begins under the Statute of Limitations (Amendment) Act 1991, s.2. Requires knowledge of injury, attribution, identity, and significance.
Non-delegable duty	A legal duty of care that cannot be discharged by subcontracting. Under Morrissey, the HSE owes this duty to every woman screened through CervicalCheck, regardless of which laboratory processed the sample.

Compensation framework and tax treatment

Compensation in this kind of claim is split between general damages (for pain, suffering, and loss of amenity) and special damages (quantifiable financial loss). General damages are set within the brackets of the Personal Injuries Guidelines (2021), which replaced the Book of Quantum in April 2021 and apply equally in the High Court and at mediation. The Guidelines cap general damages for catastrophic, life-altering injury at €550,000, which was the highest bracket approved by the Judicial Council for the most devastating injuries.

Indicative Irish cervical screening negligence compensation ranges (education only, every case turns on its facts)

Severity category	Clinical scenario	Indicative range
Minor delay	Short delay, minor additional outpatient treatment, full recovery	€50,000 to €150,000
Moderate delay	Need for hysterectomy or more invasive surgery, high survival probability	€150,000 to €350,000
Severe delay	Advanced cancer, loss of fertility, extensive chemoradiotherapy, life-limiting complications	€350,000 to €1,000,000+
Catastrophic	Terminal diagnosis or severe permanent disability requiring ongoing care	€1,000,000+ (driven by special damages)

Every case turns on its facts. The Judicial Council Guidelines govern the general-damages portion. Special damages (loss of earnings, care costs, treatment costs) can form the bulk of a multi-million-euro settlement.

Known Irish cervical screening settlements for context

The landmark Irish settlements and awards provide contextual benchmarks, not a tariff. The table below summarises the reported figures across the CervicalCheck litigation to date.

Notable Irish cervical screening settlements and awards (public information only)

Plaintiff	Year	Amount	Venue and liability position
Vicky Phelan	25 April 2018	€2.5 million	High Court settlement against Clinical Pathology Laboratories Inc (Texas), no admission of liability. Action against HSE struck out with no order
Emma Mhic Mhathúna	29 June 2018	€7.5 million	High Court settlement against HSE and Quest Diagnostics. HSE admitted liability for non-disclosure, Quest admitted misreading 2010 and 2013 slides
Ruth Morrissey (and husband Paul)	2019 (High Court), 2020 (Supreme Court)	€2.16 million	Liability determined against HSE and laboratories, affirmed on appeal
Patricia Carrick	October 2020	€2.75 million	High Court settlement reached at mediation

Every outcome reflects the facts, evidence, and medical trajectory of the individual woman concerned. Past settlement figures are not predictive of future claims.

Periodic Payment Orders and structured settlements

For catastrophic cervical screening cases involving lifelong care needs, Irish courts can order a Periodic Payment Order (PPO) instead of a single lump sum. The Civil Liability (Amendment) Act 2017 introduced statutory PPOs specifically for catastrophic injury claims where the claimant requires care into the future. Under the Act, the court can order index-linked annual payments that run for the claimant's lifetime, removing the investment risk a lump sum carries.

In a cervical screening context, PPOs typically arise where a claim settles on the basis that the claimant will need ongoing care, adapted accommodation, or continuous medical input. Unlike in England and Wales, where PPOs are indexed to ASHE 6115 by default, Ireland indexes statutory PPOs to the Harmonised Index of Consumer Prices plus a care-component adjustment where appropriate. This leads to the question of whether to accept a PPO offer, which turns on actuarial advice and the claimant's personal circumstances.

Tax treatment of settlements and ex-gratia payments

Payments made to women affected by CervicalCheck since the programme's inception in 2008 are exempt from Income Tax, Capital Gains Tax, DIRT, and Exit Tax. Revenue Manual Part 07-01-23B (2025) sets out the detailed position and the repayment claim deadlines. Payments under the non-disclosure ex-gratia scheme made since 2019 are also exempt from Capital Acquisitions Tax. If you've already received a settlement and have paid tax on it in error, repayment claims follow these statutory deadlines.

Family claims after a death

When a woman dies as a result of cervical cancer linked to screening negligence, her estate and dependants may bring a claim in Ireland under Part IV of the Civil Liability Act 1961. The claim has two components. The estate may continue the deceased's personal action for damages accrued before death, and the statutory dependants may claim for loss of financial support and services under the fatal injuries provisions.

The "solatium" payment for mental distress to statutory dependants is capped at a total of €35,000 shared among all qualifying dependants, not per dependant. That figure was set by Section 49 of the Civil Liability Act 1961 and last revised by Ministerial Order (S.I. No. 6 of 2014) with effect from 11 January 2014. The cap has remained unchanged since. Dependants may also recover the reasonable cost of services the deceased previously provided to the family, subject to the limits explored by the Supreme Court in Morrissey.

How fatal injuries damages are calculated in Ireland

A fatal cervical screening claim typically produces four distinct heads of damage under the Civil Liability Act 1961. Understanding how each head works helps families set realistic expectations before proceedings issue.

Heads of damage in fatal Irish cervical screening claims

Head of damage	What it covers	Typical scale
Solatium (mental distress)	Mental distress payment to qualifying statutory dependants	€35,000 total, shared among all dependants
Loss of dependency (pecuniary)	Loss of the deceased's future earnings that would have supported dependants	Actuarial calculation based on earnings, life expectancy, and dependency ratio
Loss of services	Cost of replacing household services (childcare, homemaking) the deceased provided	Vouched at market rates, can exceed loss of earnings in some cases
Estate continuation of personal action	Pain, suffering, and special damages accrued before death	Depends on duration and severity between diagnosis and death

The four heads are cumulative. A fatal cervical screening claim can run into seven figures where the deceased had earning capacity and dependent children, even though the solatium alone is modest.

Secondary victim and nervous shock claims by family members

Secondary victim claims by relatives of a woman harmed by cervical screening failure are exceptionally difficult in Ireland and governed by the five-part test in Kelly v Hennessy [1995] 3 IR 253. A claimant must show recognised psychiatric injury caused by a sudden shocking event, with a close tie of love and affection, proximity to the event or its immediate aftermath, and that the injury was reasonably foreseeable. For screening negligence, the "sudden shocking event" limb is particularly hard to satisfy.

Recent authority has narrowed the door further. In both Morrissey v HSE and Mitchell v HSE, the courts held that the National Screening Service and its contracted laboratories don't owe a direct duty of care to the spouses of women being screened. The High Court in Germaine v Day held that a widow's gradual witnessing of her husband's decline from a misdiagnosed cancer didn't meet the "sudden shocking event" threshold.

What might satisfy the Kelly v Hennessy test

Most pages explain what fails. Closing the loop on what could succeed matters just as much. A secondary victim claim in a cervical screening context is most likely to survive where a family member was present at a single, identifiable, shocking moment, for example: a surgical theatre where a catastrophic complication unfolded visibly, the immediate aftermath of a sudden collapse at home, or the moment of receiving a death notification in circumstances the deceased should never have been in. The trigger must be acute, not the longer arc of deterioration.

Open disclosure failure as a separate head of claim

In Ireland, an open disclosure failure can be a stackable cause of action alongside the underlying negligence claim. Part 2 of the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023²¹ commenced on 26 September 2024 and creates mandatory disclosure obligations for defined notifiable incidents in HSE-delivered services. Where disclosure doesn't occur as the Act requires, that failure sits alongside the underlying misread as a separate actionable wrong.

The practical significance for a cervical screening claim is twofold. First, the 2023 Act shifts the analysis of the "date of knowledge" because statutory disclosure should itself crystallise knowledge in most cases. Second, a disclosure failure may ground an argument for increased general damages on the grounds of compounded psychological harm, distinct from the clinical outcome itself. This is an emerging area and every case depends on its facts.

Unlike in England and Wales, where the statutory "Duty of Candour" under the Health and Social Care Act 2008 operates as a regulatory obligation enforceable only by the Care Quality Commission, the Irish framework under the 2023 Act sits directly inside the patient's civil-liability landscape. That creates a materially different claim structure for Irish claimants.

What triggers mandatory disclosure under the 2023 Act

The Schedule to the Patient Safety Act 2023 lists 13 specific "notifiable incidents" that trigger automatic mandatory disclosure obligations on health services providers. The relevant categories for cervical screening failures include serious harm arising from diagnostic error, unintended reaction to treatment, and any incident causing death or serious injury that was not an expected consequence of the underlying condition. The Act also includes specific provisions applying to the HSE's cancer screening services, obliging them to inform patients of their right to request a review of their screening.

The Act sets structured timeframes for disclosure. An initial open disclosure meeting must be offered as soon as reasonably practicable after the healthcare provider becomes aware of the incident. A written statement of the known facts must follow. Each stage must be documented, and the patient is entitled to a support person throughout. Failure at any stage can ground both a regulatory sanction and, in practice, an additional head of civil claim.

The €20,000 non-disclosure ex-gratia scheme

The non-disclosure ex-gratia scheme is a separate, administrative compensation route, not a negligence claim. Approved by Government on 11 March 2019 following the Scally report, it pays a fixed sum of €20,000 to each woman in the CervicalCheck audit cohort where an Independent Assessment Panel determines that appropriate disclosure didn't occur. The Department of Health scheme terms remain open to eligible applicants.

Accepting an ex-gratia payment does not prevent a separate High Court negligence claim. The two processes are legally distinct: the ex-gratia payment compensates for the non-disclosure failure, while a negligence claim addresses the underlying misread and its clinical consequences. Many women have received both.

Common misconceptions about cervical screening claims in Ireland, corrected

Out-of-date guidance and imported UK framings create a cluster of confident errors that damage valid Irish claims every year. The five corrections below reflect the current Irish statutory and case-law position as of 24 April 2026.

The most common misconceptions, and what the law actually says.

Common belief	What Irish law actually provides
"Medical negligence claims go to the Injuries Resolution Board first."	No. Under Personal Injuries Assessment Board Act 2003, s.3(d), medical negligence is expressly exempt. Cervical screening claims proceed directly to the High Court, and filing with the IRB does not pause the limitation clock.
"The two-year clock starts when I was diagnosed with cancer."	Not necessarily. Under Statute of Limitations (Amendment) Act 1991, s.2, the clock starts on your "date of knowledge," which can be earlier (for example, when you received an audit letter confirming a misread) or later, depending on the facts.
"I can still file with the CervicalCheck Tribunal."	No. The Tribunal was dissolved on 30 January 2026 by S.I. No. 19/2026. Every new claim from that date issues in the High Court Clinical Negligence List under Practice Direction HC132.
"Ireland applies the same legal test as England and Wales."	No. Irish courts apply the Dunne and Morrissey "reasonable competence" test, not the Bolam/Bolitho test used in England and Wales. Irish courts place less weight on professional custom and more weight on what a competent peer would have detected.
"The HSE can avoid liability by blaming the private laboratory."	No. Morrissey v HSE [2020] IESC 6 confirmed the HSE owes a non-delegable duty of care to women screened through CervicalCheck. The HSE remains a primary defendant even where the actual misread happened in a contracted laboratory.

Mistakes that sink cervical screening claims

Several recurring errors cause otherwise valid claims to fail.

• Assuming the two-year clock starts on the date of the cancer diagnosis. It usually starts on the date of knowledge, which can be earlier.
• Waiting for a medical expert report before issuing proceedings. Under Monaghan, the clock does not pause.
• Filing with the IRB. Medical negligence claims bypass the IRB entirely under PIAB Act 2003 s.3(d), and that filing does not stop the limitation clock.
• Relying on generic "tumour doubling time" literature for causation. Crumlish shows why claim-specific clinical expert evidence is required.
• Letting slides or records be destroyed. Request preservation in writing immediately.
• Using the dissolved CervicalCheck Tribunal Form 1 as a current route. That route has closed.

How long cervical screening negligence claims typically take

Timelines vary widely, but HC131 and the SCA's mediation-preferred posture have shortened the typical claim timeline. In our experience handling women's health misdiagnosis claims, most cervical screening cases run between 12 and 30 months from instruction to resolution where liability is reasonably clear. Contested causation, expert disagreement, or defence challenges on causation push the timeline toward three years or beyond.

Indicative timelines for these claims in Ireland

Scenario	Typical range	What affects timing
Historic CervicalCheck misread, liability accepted	12 to 18 months	SCA mediation posture, expert availability
Post-2020 HPV era misread, contested breach	18 to 30 months	Expert cytology re-reads, reagent-batch discovery
Complex causation (Crumlish-style dispute)	24 to 48 months	Gynaecological oncology expert duels
Catastrophic care cases with life-plan	24 to 36 months	Actuarial and care-cost expert preparation

These are indicative ranges based on reported Irish cases and SCA data, not guarantees. Every case depends on its own facts.

SCA claims handling: typical phase-by-phase pattern

The State Claims Agency's handling of cervical screening claims follows a reasonably consistent pattern drawn from the SCA Annual Report 2024². Understanding the rhythm helps claimants set realistic expectations and spot when a case is drifting.

Typical SCA handling phases in a cervical screening negligence claim

Phase	Typical duration	What happens
Acknowledgement of letter of claim	4 to 8 weeks	SCA confirms receipt and opens a case file with a reference number
Initial investigation	3 to 6 months	SCA instructs its own experts, reviews records, takes statements from HSE and laboratory staff
Pleadings phase	6 to 9 months	Summons, Statement of Claim, Defence, Reply, and any particulars exchanged
Exchange of expert reports	3 to 6 months	Plaintiff's and defendant's cytology, oncology, and care experts deliver reports
Mediation window (per HC131)	3 to 4 weeks	Mediation offered and day fixed once trial date is secured
Trial or settlement	1 to 3 days if trial, single day if mediation	Majority (approximately 43% by SCA figures) resolved through mediation

These phases overlap in practice. A well-prepared plaintiff can shorten the overall timeline by front-loading the expert report and records request before proceedings issue.

How to claim after a suspected cervical screening failure in Ireland

Estimated effort: 60 to 90 minutes for initial steps. What you need: a list of smear test dates, the name of any laboratory mentioned, GP and hospital details, any letters received from CervicalCheck.

1. Request your records and slides in writing from Client Services, NSS, King's Inns House, 200 Parnell Street, Dublin 1, D01 A3Y8. Ask for a personal cervical screening review if you've had a cancer diagnosis. Records request page⁴
2. Note your date of knowledge the moment you receive a review finding or learn of a possible misread. The two-year clock likely starts now. 1991 Act s.2¹²
3. Instruct a solicitor experienced in clinical negligence. Medical negligence bypasses the IRB entirely under PIAB Act 2003 s.3(d)²⁰, so there's no IRB application to file.
4. Preserve all evidence. Ask in writing that the original slides and audit records be preserved. GPs and laboratories destroy materials on schedules that may pre-date your claim.
5. Prepare for the Clinical Negligence List. A High Court personal injuries summons will be issued. HC132⁷ case management follows.
6. Engage with mediation. Under HC131⁸, mediation is effectively mandatory before trial.

What to bring to a first meeting with a solicitor

A well-prepared first meeting usually covers ground that a solicitor would otherwise need two or three sessions to cover. From handling initial consultations in women's health misdiagnosis cases, the documents and information below consistently make the biggest difference to how quickly the file can progress.

• A chronological list of every CervicalCheck smear test you recall, with approximate dates and, where known, the laboratory named on the result letter.
• Any letters or emails from CervicalCheck, the National Screening Service, the HSE, or a hospital about audit findings, personal reviews, or retrospective discordant readings.
• A copy of any hospital discharge letters, oncology correspondence, or pathology reports relating to your diagnosis.
• Your GP's contact details and the approximate dates of any consultations relevant to the smear tests or subsequent diagnosis.
• A note of any symptoms you reported to a GP or colposcopy clinic, with approximate dates, particularly if those symptoms were dismissed or not followed up.
• Photo identification and proof of address, required for client identification under anti-money-laundering legislation.
• A list of any financial losses you've incurred so far (lost income, medical expenses, travel, childcare) with receipts where possible.

Common fears that stop women from pursuing a claim (and honest answers)

Work inside this area long enough and the same worries come up in every first meeting. They recur on boards.ie, in 221+ patient forums, and in submissions to Oireachtas health committees. None of them are irrational, and each has an honest answer grounded in Irish law.

"Will claiming rock the boat with my ongoing treatment?" No. Your treating oncology, gynaecology, and surgical teams are clinically separate from the CervicalCheck programme and its contracted laboratories. Nothing in a negligence claim reaches the teams currently treating you. The HSE is required under the Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 to continue providing care regardless of any litigation.

"Is it too late for cases from 2018 to 2020?" It depends on your date of knowledge. If you only learned of a misread after a 2023 personal review letter, the two-year clock likely started then, not in 2018. At this point, you'll need to decide whether to seek advice immediately or risk the Monaghan trap closing the door.

"What if I can't face going to court?" According to SCA data², fewer than 2% of clinical negligence claims reach a full judgment. Under HC131⁸, mediation is the default resolution mechanism, and mediation rooms in the Four Courts are private, unpublished, and typically last a single day.

"I don't want compensation, I want answers." This leads to the question of what a claim actually produces. A negligence claim routinely generates a full independent slide re-read, an oncology report on causation, and written admissions or denials from each defendant. Many families who start the process describe the answers as more valuable than the monetary outcome.

Costs protection: what adverse costs exposure actually looks like

The fear that losing a cervical screening claim means facing a catastrophic costs order is not quite accurate in Ireland. Under Order 99 of the Rules of the Superior Courts and the Legal Services Regulation Act 2015, costs follow the event, but several protective mechanisms change the practical picture in clinical negligence cases.

First, lodgments under Order 22 RSC require defendants who wish to protect themselves on costs to pay money into court. Where the claimant does better than that lodgment, the defendant pays the claimant's costs. Second, Calderbank offers (without-prejudice offers marked "save as to costs") function similarly as a cost-shifting tool. Third, the State Claims Agency's own published policy favours negotiated outcomes over punitive costs pursuit against unsuccessful plaintiffs, particularly in sensitive YMYL-adjacent cases like cervical screening.

Unlike in England and Wales, where Qualified One-Way Costs Shifting (QOCS) gives automatic costs protection to personal injury claimants under CPR 44.14, Ireland has no equivalent automatic shield. This makes the lodgment and Calderbank tools more important here, and makes the initial solicitor conversation on costs exposure essential before proceedings issue. Your solicitor is required under SI 644 of 2020 to give you a written estimate of likely fees and outlays.

Evidence preservation: what to ask for in writing today

Even before you instruct a solicitor, writing a short preservation request to your GP, the laboratory, and the National Screening Service protects the most valuable evidence in any cervical screening claim. Without a preservation request, slides and audit materials are subject to routine destruction schedules that often pre-date the limitation period.

A preservation request should be sent by recorded post and should explicitly: identify you by name, date of birth, and address, reference the approximate dates of the smear tests concerned, ask that original slides, slide-level audit data, reagent-batch records, and all correspondence be preserved pending potential legal proceedings, and ask for written confirmation of compliance within 21 days. A copy should go to the laboratory manager, the GP practice manager, and Client Services at the NSS.

Template letter: evidence preservation request

Template letter: request for a personal cervical screening review

Both templates are educational only. Every woman's situation is different, and a solicitor can tailor the correspondence to your specific circumstances.

Common questions about cervical screening negligence claims in Ireland

Is the CervicalCheck Tribunal still open in 2026?

No. The Tribunal was dissolved by Ministerial Order on 30 January 2026 under S.I. No. 19/2026. All new cervical screening claims now go to the High Court.

• Final annual report lodged February 2024.
• Total claims received: 26.
• Residual queries go to the Department of Health.

Why this matters: older guides and articles still point readers to a route that has closed.

Sources: S.I. No. 19/2026 (2026)¹ • Tribunal Act 2019⁵

How long do I have to make a claim?

Two years from your date of knowledge, not from the date of the misread smear. Under the 1991 Act, the clock starts when you first knew, or ought to have known, that the misread caused you harm and the identity of those responsible.

• Monaghan v Molony: waiting for an expert report does not stop time.
• Minors: time runs from their 18th birthday.
• Incapacity: clock suspended until capacity returns.

Why this catches people out: date-of-knowledge errors cause most time-barred claims.

Primary source: 1991 Act s.2 (revised)¹² • Time limits guide

Do I need to file with the Injuries Resolution Board first?

No. Medical negligence claims in Ireland bypass the IRB entirely under Section 3(d) of the PIAB Act 2003. Cervical screening negligence cases proceed directly to the High Court. Filing with the IRB does not stop the limitation clock.

• IRB exemption covers every clinical negligence action.
• Only a Personal Injuries Summons in the High Court stops the clock.
• The SCA defends on behalf of the HSE and statutory bodies.

The practical effect: attempting the IRB route can run down your two years.

For the statutory basis: PIAB Act 2003 s.3(d)²⁰ • Medical negligence overview

What is the Morrissey "reasonable competence" standard?

Morrissey v HSE [2020] IESC 6 confirmed that a cervical screener must not report a slide as normal if any abnormality a competent screener exercising ordinary care would have detected is present. This is the legal test applied to every such claim in Ireland.

• "Absolute confidence" standard was rejected.
• HSE non-delegable duty confirmed.
• Independent labs owe a direct duty to the patient.

Why this point comes up: this is the test your expert must apply to the original slide.

Supporting authority: Morrissey judgment (2020)⁹ • Women's health misdiagnosis

Does Morrissey still apply to post-2020 HPV primary screening?

Yes. The Dunne-Morrissey "reasonable competence" test applies to every form of cervical screening in Ireland, including HPV primary testing. The specific failure mode has shifted toward specimen-collection errors, HPV triage errors, and failed recall or referral, but the legal standard is the same.

• HPV test false negatives are actionable.
• Failure to refer for colposcopy is actionable.
• "Vaccine assumption bias" on Gardasil 9 is an emerging ground.

In practice: new cases continue to emerge from post-2020 screening.

Where to verify: Pathology lab errors • Advanced cervical cancer diagnosis

Can my family make a claim if I have died from cervical cancer?

Yes. A claim can be brought by your estate for damages accrued before death and by your statutory dependants under Part IV of the Civil Liability Act 1961. A solatium for mental distress is capped at €35,000 shared among all qualifying dependants.

• Estate continues the personal injury action.
• Dependants claim for loss of support and services.
• Date of knowledge is the deceased's, not the family's.

What this means: preserving the personal action before death protects general damages.

Underlying rule: Claims after death • Civil Liability Act 1961

Can I receive both the €20,000 ex-gratia payment and damages from a claim?

Yes. The non-disclosure ex-gratia scheme and a High Court negligence claim are legally distinct routes. The ex-gratia payment addresses the communication failure (non-disclosure of an audit), while a negligence claim addresses the underlying misread and its clinical effects.

• Scheme pays a fixed €20,000 via an Independent Assessment Panel.
• Negligence damages are assessed by the court or at mediation.
• Both are tax-exempt under Revenue Part 07-01-23B.

Why we flag it: accepting the ex-gratia payment does not release your negligence claim.

Read more: Ex-gratia scheme terms¹⁹ • Revenue Manual 07-01-23B¹⁸

Is an interval cancer always evidence of negligence?

No. An interval cancer is a cancer diagnosed between routine screenings, and the HSE describes it as an inherent feature of every screening programme. Only a proportion of interval cancers trace back to a negligent misread or failed follow-up.

• Around 20-30 interval cancers occur in Ireland each year.
• Independent slide re-read determines if the earlier smear missed an abnormality.
• A personal cervical screening review helps answer this.

Why this is important: an interval diagnosis triggers review, not automatic liability.

Source material: HSE interval cancer guidance¹¹ • Personal review

Will my claim go to a full High Court trial?

Probably not. According to the State Claims Agency's 2024 figures, 43% of clinical negligence claims with damages resolved through mediation, and fewer than 2% reached a full judgment. HC131 makes mediation effectively compulsory before trial.

• HC131 requires a mediation offer within three weeks of a trial date.
• Parties must engage within six weeks.
• The SCA prefers mediation for complex clinical claims.

The reason this matters: being trial-ready is what usually brings a strong mediation offer.

Authority: Mediation in medical negligence • HC131⁸

What happens with legal costs if I lose the case?

Under Ireland's general costs-follow-the-event principle, an unsuccessful claimant can in principle be ordered to pay the defendant's costs. Several funding arrangements and cost-protection measures are discussed with clients before proceedings issue, and protective cost orders are sometimes available in appropriate clinical negligence cases.

• Every solicitor must comply with SI 644 of 2020 on fee transparency.
• No outcome can be guaranteed in advance of proceedings.
• Discuss costs protection options with your solicitor at the first meeting.

Why we raise this: costs exposure is the single most overlooked element of litigation.

Supporting material: Medical negligence legal costs • Legal Services Regulatory Authority

Related questions you may be asking next

What if my smear was misread in another EU country? Jurisdictional rules under Brussels I (Recast) usually permit the Irish courts to hear a claim where harm was suffered in Ireland, but this is fact-dependent and warrants early legal advice.

Can I sue the US laboratory directly? Yes, historically many CervicalCheck claims have been brought directly against US laboratories including Quest Diagnostics and Clinical Pathology Laboratories. Service out of the jurisdiction and enforcement of judgments are specialist steps.

About the author

Gary Matthews is the Principal Solicitor at Gary Matthews Solicitors in Dublin, practising at 3rd Floor, Ormond Building, 31-36 Ormond Quay Upper, Dublin D07. He holds Law Society of Ireland Practising Certificate No. S8178 and is regulated by the Law Society of Ireland.

The firm advises on medical negligence claims across Ireland, including cervical screening negligence, maternity and birth injury, cancer misdiagnosis, and hospital negligence. This guide was written and reviewed by the firm's medical negligence team and last checked on 23 April 2026 against the primary Irish statutory and case-law sources cited in the References section.

Contact: 01 903 6408 • info@personalinjurysolicitorsdublin.info • Medical negligence practice area

References

Sources below were verified on 23 April 2026.

1. S.I. No. 19/2026, CervicalCheck Tribunal (Dissolution) Order 2026, Irish Statute Book, made 27 January 2026, commenced 30 January 2026.
2. State Claims Agency Annual Report 2024, National Treasury Management Agency, published 15 July 2025.
3. CervicalCheck now providing personal cervical screening reviews, HSE National Screening Service, published 4 April 2023.
4. Accessing your cervical screening records and requesting reviews, HSE, updated 2025.
5. CervicalCheck Tribunal Act 2019 (No. 31 of 2019, Revised), Law Reform Commission.
6. 'Doomed to fail': CervicalCheck tribunal cost €3.4m but made no awards, Irish Examiner, 20 June 2025.
7. Practice Direction HC132, Clinical Negligence List, President of the High Court, effective 28 April 2025.
8. Practice Direction HC131, Clinical Negligence Actions: Applications for Trial Dates, President of the High Court, effective 28 April 2025.
9. Morrissey v HSE [2020] IESC 6, Supreme Court of Ireland, judgment delivered 19 March 2020 (Clarke CJ). BAILII parallel citation: bailii.org.
10. Dunne v National Maternity Hospital [1989] IR 91, Supreme Court of Ireland, judgment delivered 14 April 1989 (Finlay CJ). Judgment pre-dates the Courts Service online database. See Wikipedia summary for overview.
11. Interval cancer: a cervical cancer diagnosis between screening tests, HSE, updated 2025.
12. Statute of Limitations (Amendment) Act 1991, s.2 (No. 18 of 1991, Revised), Law Reform Commission.
13. Taking and appealing a civil case (time limits for civil legal action), Citizens Information, updated 2025.
14. About the cervical screening programme, HSE CervicalCheck, updated 2025.
15. Access to records and requesting reviews, HSE, updated 2025.
16. 368 legal claims brought over CervicalCheck while Tribunal registers just 25, Irish Examiner, 24 September 2022.
17. Personal Injuries Guidelines 2021, Judicial Council of Ireland, effective 24 April 2021.
18. Revenue Manual Part 07-01-23B, Tax Treatment of CervicalCheck Payments, Revenue Commissioners, updated 2025.
19. CervicalCheck Non-Disclosure Ex-Gratia Scheme, Terms of Reference, Department of Health, approved by Government 11 March 2019.
20. Personal Injuries Assessment Board Act 2003, s.3 (No. 46 of 2003, Revised), Law Reform Commission.
21. Patient Safety (Notifiable Incidents and Open Disclosure) Act 2023 (No. 10 of 2023), Irish Statute Book, commenced 26 September 2024.

Further resources

Courts Service of Ireland, practice directions and court listings.

221+ Patient Support Group, patient advocacy and support for women affected by CervicalCheck.

Irish Cancer Society, cervical cancer screening guidance.

Related guides from Gary Matthews Solicitors: Medical negligence overview • Cancer misdiagnosis • Pathology lab errors • Women's health misdiagnosis • Time limits • Claims after death • Secondary victim claims

Disclaimer: This information is for educational purposes only and does not constitute legal advice. Every case is different, outcomes vary, and solicitors can't guarantee any result. If you believe you may have a claim of this kind, please seek advice from a qualified solicitor tailored to your specific circumstances. Gary Matthews Solicitors is regulated by the Law Society of Ireland. In contentious business, a solicitor may not calculate fees as a percentage or proportion of any award or settlement.